Surgery for MDS Tampa FL
Surgery in the traditional sense is not used for treating MDS (myelodysplastic syndromes), although patients with these conditions may undergo any of several advanced procedures at Moffitt Cancer Center in Tampa, Florida. Bone marrow biopsies (surgical procedures used to diagnose myelodysplastic syndromes) and surgical central port placement (used to streamline regular blood transfusions) are two such procedures that are frequently performed by Moffitt’s Malignant Hematology team – a group of physicians with experience in medical oncology, radiation oncology, surgery and other treatments for MDS.
Moffitt’s Malignant Hematology Program is one of the largest and most widely recognized in the nation, offering a comprehensive range of myelodysplastic syndrome treatments in a single location that’s easily accessible from all parts of Tampa. Moffitt’s team specializes in:
- Diagnosing each of the unique myelodysplastic syndromes
- Creating individualized profiles based on the unique genetic makeup of each patient’s condition
- Monitoring patients who have low blood counts and elect “watchful waiting” because they have few or no symptoms
- Performing potentially curative stem cell transplants
- Administering medication therapy and other supportive treatments to help boost low blood counts
- Tracking each patient’s progress and adjusting treatment plans as necessary over time
When a surgical procedure is recommended as part of a patient’s treatment plan, the operation will be performed by a surgeon who specializes exclusively in MDS surgery. This high level of specialization allows for the best possible outcomes and quality of life for our patients.
To learn more about how surgery is used for MDS, call 1-888-663-3488 or submit a new patient registration form online. Patients from Tampa, FL, and beyond are welcome to consult with our experienced oncologists with or without physician referrals.
Myelodysplastic Syndromes (MDS)
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous Lymphoma (CTCL)
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer